No supplier or customer ties in ECOR's filings yet. The map draws only what companies disclose to the SEC; ties named in other companies' filings join as the graph reads them.
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Nothing on the wire mentions ECOR yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How ECOR has moved on past release days vs its typical ±3.5% day, and how often it closed up. Computed from daily closes — not a forecast.